Type 1 diabetes: etiology, immunology, and therapeutic strategies.
about
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceThe involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genesReversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cellsScreening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversyPositive evidence for vitamin A role in prevention of type 1 diabetesRecent advances in understanding Type 1 DiabetesGenetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's DiseaseStem cell therapy to cure type 1 diabetes: from hype to hope.Metabolomics applied to the pancreatic isletPurinergic signalling and diabetesRole of T cells in type 2 diabetic nephropathyDiabetes mellitus related bone metabolism and periodontal diseaseMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusNew opportunities: harnessing induced pluripotency for discovery in diabetes and metabolismType 1 diabetesRisk factors and primary prevention trials for type 1 diabetesLow-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunityNetwork for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetesCell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsInsulitis in human type 1 diabetes: a comparison between patients and animal modelsDiabetes, insulin-mediated glucose metabolism and Sertoli/blood-testis barrier functionIL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetesAutoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1Imaging pancreatic islet cells by positron emission tomographyAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsRegulation of tumour necrosis factor signalling: live or let diePneumococcal Polysaccharide Vaccination Elicits IgG Anti-A/B Blood Group Antibodies in Healthy Individuals and Patients with Type I Diabetes MellitusGW8510 increases insulin expression in pancreatic alpha cells through activation of p53 transcriptional activityQuantitative-proteomic comparison of alpha and Beta cells to uncover novel targets for lineage reprogrammingEndoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1β-induced apoptosis via Bim/A1 imbalanceIntegrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's diseaseImmunological biomarkers: catalysts for translational advances in autoimmune diabetesDefinition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms.The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on OsteopeniaA20 Inhibits β-Cell Apoptosis by Multiple Mechanisms and Predicts Residual β-Cell Function in Type 1 Diabetes.Integrative analysis of the transcriptome profiles observed in type 1, type 2 and gestational diabetes mellitus reveals the role of inflammationEarly prediction of autoimmune (type 1) diabetes.
P2860
Q21144940-83B0A6A9-C76E-42B1-974B-C661BC55DEF0Q21195858-74371BA5-C7A9-4B71-8552-3AD5D8854D01Q21245299-95FD43A1-51DA-4FDE-B704-0B3606F681ADQ26740345-E3652345-F29F-49B4-8B48-5CC1AAAE6694Q26751004-04FA9691-7D02-4DB0-B382-C1148A1AB25DQ26766139-AFEC267D-CDCF-4A29-AEEF-E6457FF1CE45Q26770562-B471849E-2B6D-4850-B804-149572F66019Q26823294-52727C2C-E8CB-41EC-976D-2C34F2C49BAFQ26824852-7D22206C-6123-43D8-80BE-EE8895D8683AQ26828574-A2EF05FA-F998-4EF0-9C27-F8765151BF9BQ26849691-0B58DA9E-4550-435D-A1CC-5659D43EDC1DQ26852990-BE702D94-361A-4830-B59A-68FC93A606F8Q26864580-BD3589AE-F819-48B4-85F1-D6136A082E5FQ26995562-6268C895-3F7C-42AE-803E-9C55DCBDB8BAQ27000491-E937C8AA-4AE1-47FD-B715-156A07E26389Q27005625-25A3906C-4D1C-476F-B5D8-054510319C3FQ27008200-2B80B502-B0E3-4A48-8587-B8EF0883CFB2Q27009104-56D789CC-7501-4274-829F-7DB8C78F7036Q27022532-35B1A8F1-432D-4840-9E2D-C28240E9CC7AQ27023712-421D6F07-5F06-4189-9CBC-6831ECBEBE67Q27027422-8E372F80-176D-4101-B5D9-0085658FF632Q27303126-88C94462-3AFB-46B6-9648-83771615387EQ27348019-ED404CE4-8374-42FB-80A7-E2351A473CD7Q28075496-BBF25A65-8F58-4096-8EAC-D51E7B46E4C3Q28080791-018B3B66-3ED8-4216-991F-3147B15C0E6CQ28085080-4644A8F6-2830-4078-A9DD-043F6A5B5C1CQ28262381-B4914466-FFCE-40FD-9893-97775194AB38Q28394046-9BF635ED-0BB3-4AE3-A304-5F03EBF96C97Q28478710-5EA8DE53-BC48-49A9-90CD-0EBB67013124Q28538153-EFDF2176-4F9A-48FF-A9F0-5FE1F2BBD444Q28574313-292757A0-F2E7-45F6-BD25-EA75EF089048Q28677042-0AA2270A-0AC4-4318-956F-237D339149DCQ28708984-40A6BB13-7115-43AD-B74E-50B04AF148ABQ30412750-48A7FE34-3163-4DE6-B5BD-1AAAB30EB842Q31132948-6CDC37CC-51AE-4F25-87F0-DAE56EC32181Q33584702-01A0A18F-9266-4EE9-AC88-FF357AE980B4Q33588206-3D17F70B-BA08-4882-A446-276287DD91BEQ33631445-33AD8AAC-EF5C-4530-9182-8A2F9E1E0F08Q33789205-E969ECF1-55EA-4C1D-AE3F-F385A9E1BE6CQ33854613-077DC994-A2F9-4FC1-836B-6FC219EF2481
P2860
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@en
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@nl
type
label
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@en
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@nl
prefLabel
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@en
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@nl
P2093
P2860
P1476
Type 1 diabetes: etiology, immunology, and therapeutic strategies.
@en
P2093
Ken T Coppieters
Matthias G von Herrath
Tom L van Belle
P2860
P304
P356
10.1152/PHYSREV.00003.2010
P577
2011-01-01T00:00:00Z